Skip to main content
Equibles

Laurion Capital Management LP

Position in PEPG — PepGen Inc.

CIK 1390202 NEW YORK, NY
Back to PEPG Full portfolio

Position in PEPG

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,951,539
+$82,526 QoQ
Shares Held
2,750,855
0.0% QoQ
Ownership
3.97%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#4
of 72 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PEPG Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names. PEPG ranks #9 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,352,234 $100,714,388
2 MLYS
Mineralys Therapeutics, Inc.
 2,506,152 $67,615,980
3 NUVB
Nuvation Bio Inc.
 7,820,013 $44,417,673
4 BBOT
BridgeBio Oncology Therapeutics, Inc.
 2,002,701 $15,260,581
5 PYXS
Pyxis Oncology, Inc.
 4,900,888 $14,751,672
6 IMUX
Immunic, Inc.
 610,326 $9,380,710
7 AARD
Aardvark Therapeutics, Inc.
 1,034,459 $5,958,483
8 AUTL
Autolus Therapeutics plc
 3,316,626 $5,306,601

All Filings in PEPG

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,951,539 2,750,855
2026-03-31 $4,869,013 2,750,855
2025-12-31 $13,359,385 2,052,133
2025-09-30 $8,741,760 1,892,156
2025-06-30 $899,944 810,761
2025-03-31 $1,139,119 810,761
2024-12-31 $3,072,784 810,761
2024-09-30 $6,932,006 810,761
2024-06-30 $13,429,238 841,431
2024-03-31 $12,369,035 841,431
2023-12-31 $4,518,708 664,516
2023-09-30 $3,375,741 664,516
2023-06-30 $5,940,773 664,516
2023-03-31 $8,127,030 664,516
2022-12-31 $8,884,578 664,516
2022-09-30 $6,033,805 664,516
2022-06-30 $6,598,643 664,516